Details of the Drug

General Information of Drug (ID: DMR34X5)

• Drug Name: GRN1005

Indication

Disease Entry	ICD 11	Status	REF
Brain metastases	2D50	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 46884921
  TTD ID: D0Y5MY

References

• [1] ClinicalTrials.gov (NCT01497665) GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L). U.S. National Institutes of Health.